Cartesian Therapeutics
RNAC
#6980
Rank
$0.44 B
Marketcap
$17.52
Share price
-4.31%
Change (1 day)
-19.89%
Change (1 year)

Cartesian Therapeutics (RNAC) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $0.45 Billion USD

According to Cartesian Therapeutics's latest financial reports the company's total liabilities are $0.45 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cartesian Therapeutics - Total liabilities on balance sheet (from 2015 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.74 B934.21%
2022-12-31$72.05 M-47.54%
2021-12-31$0.13 B-25.12%
2020-12-31$0.18 B101.2%
2019-12-31$91.17 M82.71%
2018-12-31$49.9 M1.25%
2017-12-31$49.28 M43.51%
2016-12-31$34.34 M-78.44%
2015-12-31$0.15 B44.86%
2014-12-31$0.10 B